Apple Inc., in a recent press release statement, announced the general availability of ECG app on Apple Watch Series 4 for Hong Kong and European customers, including France, Germany, Italy, Spain, and the United Kingdom.
The ECG app, which is part of the free watchOS 5.2 software update, features an electrocardiogram monitor and is apt at capturing heart rhythm on demand in a moment when users experience symptoms such as a rapid or skipped heartbeat, providing clinically important data to diagnostic physicians. The irregular rhythm notification feature on the Apple Watch occasionally monitors heart rhythm in the background and triggers a notification alert if it senses an irregular heart rhythm i.e. atrial fibrillation (AFib).
Apple, which got the De Novo clearance in the US from the FDA, is in the clear in the European Economic Area (EEA), with its ECG app1 and irregular rhythm notification2 now CE marked.
“We’ve seen the ECG app and irregular rhythm notifications on Apple Watch have a meaningful impact on our customers across the United States,” stated Jeff Williams, Apple’s chief operating officer. “We are excited to bring these features to customers in Europe and Hong Kong, giving them access to empowering information about their heart health.”